Lipsovir® prevents cold sores. Phase III clinical trial results presented at a press conference today

Lipsovir® prevents cold sores. Phase III clinical trial results presented at a
press conference today

At the press conference today the results from the clinical phase III trial for
Lipsovir® were presented. The presentation is now available on Medivirs'
web-site:
www.medivir.se 


For additional information, please contact: 
Rein Piir, Medivir's CFO & VP Investor Relations. 
+46 8 5468 3123 or +46 708 537292